ASX:RACBiotechs
Race Oncology (ASX:RAC): Evaluating Valuation After Breakthrough Discovery in Cancer Therapy Mechanism
Race Oncology (ASX:RAC) is drawing fresh attention after revealing a breakthrough discovery on how its leading drug, bisantrene, fights cancer. This scientific milestone highlights new prospects for targeted therapies and business growth.
See our latest analysis for Race Oncology.
Following the news of this breakthrough, Race Oncology shares saw strong momentum, briefly surging nearly 30% over the week. While recent excitement has moderated, the company’s total shareholder return of over 1%...